New clinical trial where stem cell transplants will be used in treating Crohn’s disease

10th August 2018

Nottingham scientists and clinicians are involved in a new clinical trial which aims to use stem cell transplants to grow a new immune system for people with untreatable Crohn’s disease – a painful and chronic intestinal disease which affects at least 115,000 people in the UK.

Crohn’s disease is a long-term condition that causes inflammation of the lining of the digestive system, and results in diarrhoea, abdominal pain, extreme tiredness and other symptoms that significantly affect quality of life.

Professor Yash Mahida, Professor of Medicine at the University of Nottingham and one of the researchers leading Gastro-intestinal research as part of the NIHR Nottingham Biomedical Research Centre said: “This trial has the potential to transform patient’s lives which are greatly impacted by the debilitating effects of Crohn’s disease. It is an important part of the work we are doing at the Nottingham Biomedical Research Centre to advance our knowledge of inflammatory bowel disease.”

Read the full NUH press release

If you would like to hear more information about the study, and/or if you would like to participate in the study please use the below contacts.

Study Contacts

Dr Gordon Moran, Principal Investigator Gordon.Moran@nottingham.ac.uk

Suzanne Henry, Senior Research Nurse Suzanne.Henry@nuh.nhs.uk

Maggie Langley, Senior Research Nurse Margaret.Langley@nuh.nhs.uk